Early Product Development

With you from all angles of translational development.

Our Early Product Development team brings together global strength and human care. Through Phase IIa, we can provide data-supported solutions nimble enough to fit your scientific and regulatory needs.

We can help with: 

• Dedicated clinical operations teams with deep understanding of all aspects of early clinical activity and site management (safety, labs, monitoring, technical training, cohort review, and recruitment screening)
• Operational flexibility for uniquely customized solutions like multi-stage dose escalation protocols and adaptive designs
• Integrated planning and management to take programs from IND through Proof-of-Concept under a single contract
• Unique clinical SOPs that cover clinical operations, project management, clinical monitoring, feasibility, start-up, and a Phase I-II site network
• Therapeutically-aligned teams focused on oncology, CNS, respiratory/autoimmune, hepatic and renal failure, and pediatrics
• More than 90 dedicated global employees executing studies in North America, Europe, and Asia-Pacific